ASHG 2026 · Tier 2–3 Academic
Wellcome Sanger Institute at ASHG 2026
Cambridge, UK
Wellcome Sanger Institute at ASHG 2026 in Montréal: 8 presentations (5 posters, 2 lightning talks, 1 platform talk); 4 research groups.
8
presentations on the program
4
research groups identified
1
sessions invited to or moderated
2
Reviewers’ Choice abstracts
| Organization | ASHG 2026 Attendance |
|---|---|
Wellcome Sanger Institute Cambridge, UK | 3 PhD Students · 2 Postdocs · 1 Staff Scientist |
Anderson Groupsanger.ac.uk/group/anderson-group Uses whole-exome, whole-genome and single-cell RNA sequencing plus genome-wide CRISPR screens to study immune-mediated disease. Focuses on inflammatory bowel disease, drug targets and treatment response.
| Poster Wed Oct 21 2:30 pm Deep generative modelling of large-scale blood single-cell RNA sequencing defines cell type-specific, clinically relevant archetypes in inflammatory bowel disease Complex diseasesGenomicsMachine learningPrecision medicine Poster Thu Oct 22 4:15 pm Isoform usage landscape in the gut revealed by long-read single-cell RNA-seq Alternative splicingAutoimmune disorderGastrointestinal systemGene regulation Moderator Fri Oct 23 11:00 am |
Trynka Groupsanger.ac.uk/group/trynka-group Generates single-cell transcriptomic, CRISPR-screen and high-throughput imaging data in immune cells. Links genetic variants to immune disease mechanisms and therapeutic discovery.
| Talk Thu Oct 22 9:00 am From eQTL to function: Dissecting genetic control of Treg suppression Autoimmune disorderExpression quantitative trait lociGenome editing/CRISPRSingle-cell Poster Thu Oct 22 4:15 pm Mapping immune-mediated disease variants to cellular function through multimodal profiling of CD4+ T cell activation Complex diseasesGenotype-phenotype correlationsImmune systemMulti-omics |
Hurles Groupsanger.ac.uk/group/hurles-group Studies rare developmental conditions using experimental cell models, exon-arrayCGH and trio exome sequencing. Works with DDD, Genomics England and PAGE.
| Talk Wed Oct 21 1:35 pm Analysis of 184,786 developmental disorder trios identifies over a hundred novel DD-associated genes and candidate haplolethal genes Identification of disease genesIntellectual and developmental disabilityExome/genome sequencingMendelian disorder Poster Fri Oct 23 2:30 pm ★ Reviewers’ Choice Analysis of 184,786 developmental disorder trios identifies over a hundred novel DD-associated genes and candidate haplolethal genesExome/genome sequencingIdentification of disease genesIntellectual and developmental disabilityMendelian disorder |
Vento-Tormo Groupsanger.ac.uk/group/vento-tormo-group Studies tissue organisation using spatial multiomics, whole-genome sequencing, AI/ML and single-cell techniques. Builds disease models for women’s health and human development.
| Talk Wed Oct 21 2:07 pm Integrating GWAS with a multimodal atlas of the female reproductive system reveals critical cell types and pathways in gynaecological disorders GenomicsMulti-omicsReproductive geneticsWomen's health Poster Fri Oct 23 2:30 pm ★ Reviewers’ Choice Integrating GWAS with a multimodal atlas of the female reproductive system reveals critical cell types and pathways in gynaecological disordersComplex diseasesGenomicsMulti-omicsReproductive genetics |
Meeting Wellcome Sanger Institute in Montréal?
Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.
Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction